Platelet glycoprotein IIb/IIIa receptor antagonists

By Casserly I.P.   Moliterno D.J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 419-433

Informa Healthcare

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Receptor Antagonists And Their Use In Elderly Patients

By Mak K-H.  

Drugs & Aging, Vol. 16, Iss. 3, 2000-03 ,pp. : 179-187

Adis International

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Receptor Antagonists: Current Concepts and Future Directions

By Ferguson J.J.   Zaqqa M.  

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 965-982

Adis International

Access to resources Recommend Favorite

Anti-platelet and anti-thrombosis characteristics of Z4A5, a novel selective platelet glycoprotein IIb/IIIa inhibitor, compared with eptifibatide under long-term infusion

By Shi X.L.   Shen S.   Guo M.M.   Zhang G.J.   Che J.   Wang B.   Zhou J.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 12, 2015-12 ,pp. : 810-814

Govi-Verlag

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Inhibitors in Percutaneous Coronary Intervention: Focus on the Pharmacokinetic-Pharmacodynamic Relationships of Eptifibatide

By Gilchrist I.C.  

Clinical Pharmacokinetics, Vol. 42, Iss. 8, 2003-01 ,pp. : 703-720

Adis International

Access to resources Recommend Favorite